NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields (TTFields) devices for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products for brain metastases, non-small cell lung cancer, pancreatic cancer, gastric cancer, ovarian cancer, liver cancer, and malignant pleural mesothelioma. The company markets its products in the European Union, the United Kingdom, Japan, and internationally. It has a clinical study collaboration agreement with MSD to study TTFields together with KEYNOTE, an anti-PD-1 therapy; and a strategic collaboration with Zai Lab (Shanghai) Co., Ltd. to commercialize its products in Greater China and establishes a development partnership intended to accelerate the development of TTFields in multiple solid tumor cancer indications. NovoCure Limited was incorporated in 2000 and is based in Saint Helier, Jersey. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Benaim Ely | Chief Medical Officer | May 11 | Sale | 61.25 | 2,135 | 130,769 | 34,846 | May 12 04:30 PM | Benaim Ely | Chief Medical Officer | May 10 | Sale | 65.16 | 2,070 | 134,877 | 36,981 | May 12 04:30 PM | Shah Pritesh | Chief Commercial Officer | Mar 09 | Sale | 71.19 | 3,669 | 261,196 | 83,187 | Mar 11 04:54 PM | Leonard Frank X | Chief Development Officer | Mar 08 | Sale | 70.10 | 744 | 52,154 | 102,295 | Mar 09 04:55 PM | Burke William Patrick | Chief Human Resources Officer | Mar 08 | Sale | 70.10 | 1,037 | 72,694 | 55,991 | Mar 09 04:53 PM | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 08 | Sale | 70.10 | 2,923 | 204,902 | 165,102 | Mar 09 04:52 PM | Cordova Ashley | Chief Financial Officer | Mar 08 | Sale | 70.10 | 759 | 53,206 | 60,848 | Mar 09 04:51 PM | Longsworth Todd Christopher | General Counsel | Mar 08 | Sale | 70.10 | 2,339 | 163,964 | 62,462 | Mar 09 04:50 PM | DOYLE WILLIAM F | Executive Chairman | Mar 08 | Sale | 70.10 | 2,385 | 167,188 | 552,013 | Mar 09 04:48 PM | Shah Pritesh | Chief Commercial Officer | Mar 08 | Sale | 70.10 | 2,481 | 173,918 | 81,908 | Mar 09 04:56 PM | Shah Pritesh | Chief Commercial Officer | Mar 07 | Sale | 69.55 | 5,294 | 368,198 | 84,389 | Mar 09 04:56 PM | Longsworth Todd Christopher | General Counsel | Mar 04 | Sale | 70.41 | 1,973 | 138,913 | 64,801 | Mar 07 06:28 PM | Burke William Patrick | Chief Human Resources Officer | Mar 04 | Sale | 70.41 | 1,026 | 72,238 | 57,028 | Mar 07 06:17 PM | Benaim Ely | Chief Medical Officer | Mar 04 | Sale | 70.41 | 1,510 | 106,315 | 43,257 | Mar 07 06:18 PM | Shah Pritesh | Chief Commercial Officer | Mar 04 | Sale | 72.11 | 4,546 | 327,790 | 89,683 | Mar 07 06:23 PM | Cordova Ashley | Chief Financial Officer | Mar 04 | Sale | 70.41 | 556 | 39,146 | 61,607 | Mar 07 06:26 PM | Leonard Frank X | Chief Development Officer | Mar 04 | Sale | 70.41 | 555 | 39,076 | 103,039 | Mar 07 06:14 PM | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 04 | Sale | 70.41 | 2,569 | 180,876 | 168,025 | Mar 07 06:16 PM | Cordova Ashley | Chief Financial Officer | Mar 03 | Option Exercise | 14.61 | 5,040 | 73,656 | 65,888 | Mar 11 04:55 PM | Longsworth Todd Christopher | General Counsel | Mar 03 | Sale | 74.50 | 1,094 | 81,501 | 66,774 | Mar 07 06:28 PM | Cordova Ashley | Chief Financial Officer | Mar 03 | Sale | 74.50 | 1,149 | 85,598 | 62,163 | Mar 07 06:26 PM | Shah Pritesh | Chief Commercial Officer | Mar 03 | Sale | 74.50 | 997 | 74,275 | 94,229 | Mar 07 06:23 PM | Benaim Ely | Chief Medical Officer | Mar 03 | Sale | 74.50 | 803 | 59,822 | 44,767 | Mar 07 06:18 PM | Burke William Patrick | Chief Human Resources Officer | Mar 03 | Sale | 74.50 | 341 | 25,404 | 58,054 | Mar 07 06:17 PM | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 03 | Sale | 74.50 | 1,301 | 96,922 | 170,594 | Mar 07 06:16 PM | Leonard Frank X | Chief Development Officer | Mar 03 | Sale | 74.50 | 930 | 69,283 | 103,594 | Mar 07 06:14 PM | Burke William Patrick | Chief Human Resources Officer | Jan 03 | Option Exercise | 10.49 | 28,604 | 299,996 | 51,269 | Jan 05 04:52 PM | Burke William Patrick | Chief Human Resources Officer | Jan 03 | Sale | 76.00 | 3,951 | 300,263 | 41,036 | Jan 05 04:52 PM | Danziger Asaf | Chief Executive Officer | Nov 26 | Buy | 102.44 | 4,974 | 509,539 | 13,276 | Nov 29 04:48 PM | Cordova Ashley | Chief Financial Officer | Nov 02 | Sale | 107.28 | 209 | 22,421 | 41,758 | Nov 03 04:11 PM | Shah Pritesh | Chief Commercial Officer | Sep 03 | Sale | 138.68 | 501 | 69,477 | 73,512 | Sep 07 04:32 PM | Leonard Frank X | Chief Development Officer | Sep 02 | Sale | 138.23 | 540 | 74,645 | 87,153 | Sep 07 04:39 PM | Cordova Ashley | Chief Financial Officer | Sep 02 | Sale | 138.23 | 828 | 114,456 | 41,967 | Sep 07 04:37 PM | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Sep 02 | Sale | 138.23 | 181 | 25,020 | 149,899 | Sep 07 04:35 PM | Shah Pritesh | Chief Commercial Officer | Sep 02 | Sale | 138.23 | 156 | 21,564 | 74,013 | Sep 07 04:32 PM | Cordova Ashley | Chief Financial Officer | Aug 12 | Option Exercise | 28.82 | 36,624 | 1,055,329 | 54,019 | Aug 16 04:40 PM | Cordova Ashley | Chief Financial Officer | Aug 12 | Sale | 140.94 | 26,624 | 3,752,286 | 45,993 | Aug 16 04:40 PM | LEUNG GABRIEL | Director | Aug 05 | Option Exercise | 31.45 | 1,000 | 31,450 | 73,859 | Aug 06 04:39 PM | LEUNG GABRIEL | Director | Aug 05 | Sale | 152.50 | 1,000 | 152,500 | 72,859 | Aug 06 04:39 PM | Madden Martin J. | Director | Aug 05 | Sale | 153.13 | 34 | 5,206 | 384 | Aug 06 04:44 PM | Shah Pritesh | Chief Commercial Officer | Aug 04 | Sale | 148.71 | 2,063 | 306,789 | 74,169 | Aug 06 04:41 PM | Leonard Frank X | Chief Development Officer | Aug 03 | Sale | 149.43 | 328 | 49,013 | 89,158 | Aug 04 05:20 PM | Benaim Ely | Chief Medical Officer | Aug 03 | Sale | 150.11 | 464 | 69,651 | 28,144 | Aug 04 04:59 PM | Shah Pritesh | Chief Commercial Officer | Aug 03 | Sale | 149.43 | 1,654 | 247,157 | 76,232 | Aug 04 05:09 PM | DOYLE WILLIAM F | Executive Chairman | Aug 02 | Sale | 149.38 | 995 | 148,631 | 554,398 | Aug 04 05:01 PM | Leonard Frank X | Chief Development Officer | Aug 02 | Sale | 149.38 | 713 | 106,507 | 89,486 | Aug 04 05:20 PM | Benaim Ely | Chief Medical Officer | Aug 02 | Sale | 149.38 | 536 | 80,067 | 28,608 | Aug 03 05:29 PM | Shah Pritesh | Chief Commercial Officer | Jul 31 | Option Exercise | 154.01 | 3,717 | 572,455 | 85,625 | Mar 11 04:54 PM | Benaim Ely | Chief Medical Officer | Jul 30 | Option Exercise | 83.30 | 651 | 54,228 | 29,795 | Aug 03 05:29 PM | Benaim Ely | Chief Medical Officer | Jul 30 | Sale | 158.96 | 651 | 103,483 | 29,144 | Aug 03 05:29 PM | LEUNG GABRIEL | Director | Jul 06 | Option Exercise | 31.45 | 1,000 | 31,450 | 73,859 | Jul 08 05:23 PM | LEUNG GABRIEL | Director | Jul 06 | Sale | 183.54 | 1,000 | 183,540 | 72,859 | Jul 08 05:23 PM | Shah Pritesh | Chief Commercial Officer | Jun 10 | Sale | 215.00 | 23,540 | 5,061,100 | 77,732 | Jun 11 04:26 PM | LEUNG GABRIEL | Director | Jun 07 | Option Exercise | 31.45 | 1,000 | 31,450 | 73,045 | Jun 08 04:49 PM | LEUNG GABRIEL | Director | Jun 07 | Sale | 204.55 | 1,000 | 204,550 | 72,045 | Jun 08 04:49 PM | Benaim Ely | Chief Medical Officer | May 27 | Option Exercise | 47.56 | 1,833 | 87,177 | 30,887 | May 28 04:36 PM | Benaim Ely | Chief Medical Officer | May 27 | Sale | 200.00 | 1,833 | 366,600 | 29,054 | May 28 04:36 PM |
|